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Abstract: Purpose. Restenosis due to intimal hyperplasia (IH) is a major clinical problem that compromises the success 
of angioplasty and endovascular surgery. The pathogenesis of restenosis is multifactorial, involving events such as 
endothelial injury, inflammation, platelet activation, and hyperplasia of the intima, primarily as a result of vascular smooth 
muscle cell (VSMC). Resveratrol (RV) is a polyphenolic phytoalexin produced by grapes and other plants in response to 
infection of injury. RV has a demonstrated beneficial effect on restenosis from angioplasty. The molecular structure of 
RV, unfortunately, reduces its immediate clinical application. Methods. To obtain a sterile injectable solution we worked 
on the solubility of RV and its viscosity. In order to avoid fast shifting of the RV in the blood stream after intimal delivering 
we searched for a high viscosity solution. TSP, a well-known biocompatible polymer, was used to conferee a suitable 
cinematic viscosity to the vehicle for the administration by drug eluting balloon. Thirty-six male New Zealand white 
rabbits, weighting 2.8 to 3.6 kg, were assigned randomly and in equal numbers to different study groups. To induce and 
establish intimal hyperplasia in the rabbit iliac artery we performed a traumatic angioplasty with an angioplasty catheter 
and dedicated devices (GenieTM Acrostak, Geneve, CH) were used to locally deliver the novel Resveratrol compound 
(RV-c). Results and conclusions. Genie® catheter has been applied in rabbits vessels and the local delivery has resulted 
effective in reducing the restenosis both after POBA and stenting. As a matter of fact, RV-c forced in the artery wall by 
balloon expansion might accumulate in the interstitials and/or within cells avoiding the wash-out occurring of solutions. In 
our experience magnification micrographs showed a significant inhibition of vSMC proliferation when RV-c has been 
applied moreover no adverse events has been documented both in vitro and in vivo studies. 
 
